Proxy Votes Now

Home › Funds › ARK Genomic Revolution ETF

ARK Genomic Revolution ETF (ARKG) proxy voting record 2025-2026

Fund family: ARK ETF Trust · Filed by ARK ETF Trust (CIK 1579982) · SEC series S000042975

Ticker: ARKG (C000133119)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 229 with, 0 against, 0 abstentions (not counted as with management). Shareholder proposals: 0 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.

No item-level comparison with other ARK ETF Trust funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 85.6% of this fund’s 229 such votes could be given a sector; the other 33 (14.4%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care15500.0%
Industrials3100.0%
Technology1000.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1300
Audit-related310
Say-on-Pay310
Compensation150
Corporate Governance140
Capital Structure80
Other40
Extraordinary Transactions20

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
TWIST BIOSCIENCE CORPORATIONFebruary 5, 2026$225M50
10X GENOMICS, INC.June 4, 2026$169M50
CAREDX, INC.June 11, 2026$160M90
TEMPUS AI, INC.May 21, 2026$129M110
PERSONALIS, INC.May 12, 2026$112M40
ILLUMINA, INC.May 21, 2026$75M110
NATERA, INC.June 11, 2026$68M80
GUARDANT HEALTH, INC.June 17, 2026$64M50

Search this fund’s votes by company

235 ballot items at 31 meetings in 2025-2026. Download all votes (CSV)

About this fund’s record

In the 2025-2026 proxy season, ARK Genomic Revolution ETF (ARKG) voted at 31 shareholder meetings of 30 companies, on 235 ballot items in all. Where management made a recommendation, the fund followed it on 100.0% of the items and voted against it 0 times.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.